Bakuchiol, Explained: What the Head-to-Head Trial Against Retinol Actually Found
Bakuchiol gets marketed as "plant-based retinol" so often that the phrase has become a category label of its own. The actual research behind it is more specific than that tagline suggests — a handful of studies, one direct head-to-head trial, and a fairly narrow concentration range where the evidence actually applies.
What Bakuchiol Actually Is
Bakuchiol is a plant-derived compound extracted from the seeds and leaves of Psoralea corylifolia (babchi), used for centuries in Ayurvedic and Chinese medicine before cosmetic chemists took an interest in it. Structurally, it isn't related to retinoids at all — it doesn't share retinol's chemical backbone. What made it interesting to researchers was gene expression profiling that showed it activates some of the same cellular pathways as retinol, despite the completely different molecule.
Why It Got Called "Plant-Based Retinol"
A 2014 study by Chaudhuri and Bojanowski, published in the International Journal of Cosmetic Science, compared gene expression profiles of retinol and bakuchiol in a full-thickness skin substitute model. The study found bakuchiol upregulated Type I and IV collagen production in a pattern resembling retinol's known effects, and a 12-week clinical case study using a bakuchiol-formulated product reported improvement in lines, wrinkles, pigmentation, elasticity, and firmness. That gene-expression similarity — not an identical chemical structure — is the actual basis for the "retinol-like" label.
The Head-to-Head Study — 0.5% vs 0.5%, 12 Weeks
The more direct evidence comes from a 2018 randomized, double-blind trial by Dhaliwal and colleagues in the British Journal of Dermatology. Forty-four patients applied either 0.5% bakuchiol cream twice daily or 0.5% retinol cream once daily for 12 weeks, with wrinkle surface area and hyperpigmentation tracked through standardized facial photography at 0, 4, 8, and 12 weeks. Both groups showed significant, statistically similar improvement in wrinkles and hyperpigmentation — the study found no significant difference in efficacy between the two.
Same Results, Fewer Side Effects — Why
The meaningful difference in the Dhaliwal study wasn't efficacy, it was tolerability: the retinol group reported significantly more facial scaling and stinging than the bakuchiol group. This tracks with what's known about how retinol works — it accelerates cell turnover in a way that reliably causes some degree of irritation during an adjustment period, especially at higher concentrations. Bakuchiol appears to activate similar downstream collagen pathways without triggering that same turnover-driven irritation, which is the practical reason it gets recommended for retinol-sensitive skin rather than as a universal upgrade.
Does It Work the Same Way as Retinol?
Not exactly, and this matters for expectations. Retinol works through retinoic acid receptors, a well-mapped mechanism with decades of research behind it. Bakuchiol's mechanism is still less thoroughly characterized — the gene-expression similarity is well documented, but researchers haven't established that it binds the same receptors or triggers the identical downstream cascade. In practice this means bakuchiol is best understood as a compound that produces comparable visible results through a pathway that isn't fully mapped yet, not as a molecule proven to be mechanistically identical to retinol.
Concentration — What's Actually Been Tested
The clinical evidence specifically covers 0.5% bakuchiol, applied twice daily. Products formulated well below that concentration, or that list bakuchiol far down a long ingredient list, aren't necessarily delivering the dose the research is based on — a pattern that comes up with other actives sold on ingredient-name recognition rather than a stated, tested percentage. Checking whether a product lists a concentration at all is a reasonable filter before assuming it will perform like the studied formulation.
Who Actually Benefits From Switching
Bakuchiol isn't a strict upgrade over retinol for everyone. For skin that already tolerates retinol well, there's no evidence bakuchiol outperforms it — the trial showed comparable results, not superior ones. Where it earns its reputation is for people who've tried retinol and consistently reacted with scaling, stinging, or redness, including during pregnancy when retinoids are typically avoided altogether (bakuchiol carries a different, generally better-tolerated profile, though anyone pregnant or breastfeeding should still confirm any active ingredient with their doctor before use). It's also a reasonable option for sensitive skin types that react to most exfoliating or turnover-accelerating actives, since its irritation profile in the trial data was consistently milder than retinol's.
Putting a Routine in Order
1) If retinol works fine for your skin, there's no evidence bakuchiol does more — this is a tolerability swap, not a potency upgrade. 2) If retinol reliably causes scaling or stinging, 0.5% bakuchiol twice daily is the concentration the clinical comparison actually tested. 3) Check the ingredient list for a stated percentage rather than assuming any "bakuchiol" product matches the studied dose. 4) Introduce it gradually like any active, and patch-test first. 5) See a dermatologist before starting any active ingredient if you're pregnant, breastfeeding, or have reactive skin — this article summarizes published research and isn't a substitute for that consultation.
All content is fact-checked under our editorial standards.